European Antibody Congress 2010
Geneva, Switzerland (November 29 - December 01, 2010 )
The 6th annual European Antibody Congress is the World’s leading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development.
New for 2010
* New market success stories: golimumab, canakinumab, obatumumab, farletuzmab and girentuximab case studies * For the first time on the agenda: Amgen, the FDA, Chugai Pharmaceutical Co, sanofi-aventis, Sandoz, Merrimack Pharmaceuticals, AdAlta, Wilex, Vaccinex and Biocon * First ever discussion of global biosimilar antibody development and impact on the European market * Exploring radio-immunoconjugates: scientific, technical, regulatory and logistical challenges * Spectacular boat cruise on board Lake Geneva
Doporučujeme
WebArchiv
